Int J Cardiol. 2011 May 5;148(3):e66-7. doi: 10.1016/j.ijcard.2009.03.009. Epub 2009 Mar 29.
Drug eluting stents (DES) by inhibiting neointimal proliferation are associated with a much lower in-stent restenosis rate compared with bare metal stents (BMS). Studies supporting these data have included patients in whom either DES or BMS were implanted but not both. What has rarely been described is the vessel response against both types of stents in the same patient. This case illustrates the difference in neointimal hyperplasia after the deployment of a DES and a BMS in tandem lesions. Optical Coherence Tomography (OCT) at 5 years follow-up showed that neointimal proliferation had been inhibited almost entirely in the DES covered segment of the artery, in contrast to the BMS covered segment. Our images clearly demonstrated for the first time with OCT technology the different degree of neointimal proliferation between DES and BMS in the same artery.
药物洗脱支架(DES)通过抑制新生内膜增殖,与裸金属支架(BMS)相比,其支架内再狭窄率要低得多。支持这些数据的研究包括植入 DES 或 BMS 的患者,但并非同时植入两种支架。很少有研究描述的是同一患者中对这两种支架的血管反应。本病例说明了在串联病变中同时植入 DES 和 BMS 后新生内膜增生的差异。5 年随访的光学相干断层扫描(OCT)显示,DES 覆盖的动脉段几乎完全抑制了新生内膜增殖,而 BMS 覆盖的动脉段则没有。我们的图像首次使用 OCT 技术清楚地显示了同一动脉中 DES 和 BMS 之间新生内膜增殖的不同程度。